Remove measure-development
article thumbnail

Participate in the Measure Development Process in 2023

PQA

In the year ahead, PQA will continue developing innovative measure approaches for high-impact areas of care. From technical expert panels, stakeholder advisory meetings, the measure endorsement vote and convening events focused on future measure opportunities, PQA members have the opportunity to be involved each step of the way!

article thumbnail

PQA Developing Health Plan Measure for COPD Treatment Ratio

PQA

PQA, the Pharmacy Quality Alliance, has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). PQA’s MCAGs are composed of individuals with clinical, measurement and implementation expertise that is directly applicable to the concepts being considered.

40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PQA Quality Shadowing Program Builds a Deeper, More Diverse Bench for Measure Development

PQA

At PQA, our work to develop measures that matter involves a systematic, transparent and consensus-based process that includes a variety of member panels across the measure lifecycle. Individuals selected to participate in the PQA Quality Shadowing Program this year will be paired with that TEP or PQA’s Measure Update Panel.

article thumbnail

PQA Quality Shadowing Program Builds a Deeper, More Diverse Bench for Measure Development

PQA

At PQA, our work to develop measures that matter involves a systematic, transparent and consensus-based process that includes a variety of member panels across the measure lifecycle. Individuals selected to participate in the PQA Quality Shadowing Program this year will be paired with that TEP or PQA’s Measure Update Panel.

article thumbnail

STAT+: Icon acquires HumanFirst to boost support for digital tools in clinical trials

STAT

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

article thumbnail

Accelerating spectroscopic analysis for data acquisition

European Pharmaceutical Review

Researchers in Germany have developed an technique to increase the speed of spectroscopic analysis , which typically takes from minutes to hours to acquire measurement. shared that this method removes the need for specialised measuring equipment. Additionally, Scheffter et al.

article thumbnail

STAT+: Biological clocks could be the key to longer, healthier lives. But scientists don’t yet agree on what ‘aging’ is

STAT

Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

99